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Abstract 
Background: Babesia bovis is the causal agent of Asiatic redwater, transmitted by the pandemic tick Rhipicephalus 
(Boophilus) microplus. Disease control may target the tick vector using acaricides or anti-tick vaccines, or the parasite 
using chemoprophylaxis or anti-parasite vaccines. Current anti-parasite vaccines comprise live blood vaccines using 
attenuated B. bovis strains. Attenuation is attained by rapid passage that may result in different phenotypes such as 
reduced virulence, non-transmissibility by the tick vector, inability to sequester in the host (lack of limiting dilution) 
and limited genetic diversity. Attenuation and phenotypes may be linked to selection of subpopulations during rapid 
passage. The South African B. bovis S24 vaccine strain comprise a subpopulation that present low virulence, non-
transmissibility, lack of limiting dilution phenotype and the presence of a single A558 Bv80 allele. The S24 strain could 
be co-transmitted with a field strain (05-100) suggesting sexual recombination. The present study investigated the 
change in phenotype for the S24 vaccine strain during rapid passage and co-transmission.
Methods: Vaccine phenotype change during passage as well as co-transmissibility was monitored using Bv80 allele 
specific PCR, limiting dilution and Illumina-based genome sequencing.
Results: The S24 population could not be rescued from the S16 passage as previously attained suggesting that 
selection of the S24 vaccine strain was a serendipitous and stochastic event. Passage from S16 to S24 also resulted in 
loss of the limiting dilution phenotype. Genome sequencing indicated sexual recombination during co-transmission 
with the 05-100 field strain. Analysis of the recombinant strain indicate that VESA1, smORF and SBP2 family members 
are present and may be responsible for the limiting dilution phenotypes, while various regions may also be responsi-
ble for the tick transmission phenotype.
Conclusions: The molecular basis for tick transmission and limiting dilution phenotypes may be defined in future 
using selection based on these traits in combination with sexual recombination.
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Background
Asiatic redwater is a global important disease in cattle 
caused by Babesia bovis and transmitted by members 
of the Rhipicephalus (Boophilus) microplus complex [1]. 
The Rhipicephalus (B.) microplus complex is found on 
all major continents including North America, South 
America, Africa, Asia and Australia [2]. Members of the 
complex include R. (B.) australis, R. (B.) annulatus, R. 
(B.) microplus (sensu stricto) as well as several genotypes 
not yet well described [3, 4]. The vector and the disease 
were historically confined to savanna regions of wooded 
grasslands, due to restrictions of humidity and tempera-
ture [5–8]. In South Africa, the historical distribution of 
R. (B.) microplus ranged from grassland biomes of the 
Eastern Cape, southern regions of KwaZulu-Natal and 
north-eastern regions of Limpopo and North-West Prov-
inces, with scattered localities in Mpumalanga [8]. How-
ever, more recently its distribution range was extended 
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to the coastal region of the Eastern Cape and into some 
areas of the Northern and Western Cape, as well as the 
Free State [9, 10]. The South African tick strains are 
genetically related to R. (B.) microplus (sensu stricto) as 
found in South America [3, 11, 12].
Control of Asiatic red water may be accomplished 
through tick control using acaricides or the Bm86 antigen 
anti-tick vaccines (GAVAC or TickGard) [13, 14]. How-
ever, in many countries significant acaricide resistance 
has been observed [14], while the Bm86 vaccines have 
served a limited commercial niche to date [13]. The alter-
native control strategy is targeting of the B. bovis parasite 
through prophylaxis or vaccination [15, 16]. Prophylaxis 
comprises treatment of clinically sick animals with dimi-
nazene aceturate. The drawback of this lies in the time-
ous identification of clinically sick animals, since severe 
clinical symptoms may only present a few days before 
the onset of acute illness and death. This has led to the 
practice of block treatment of herds when a redwater 
outbreak is suspected, or when treating vaccinated ani-
mals using the infection and treatment method [16]. Vac-
cination generally comprises live vaccines produced in 
animals or cell culture [15]. Although a promising alter-
native, development of subunit vaccines has not proved 
to be successful yet [17].
Attenuation of live vaccines to reduce virulence, by 
repeated syringe passage through splenectomized ani-
mals has been important in the development of effective 
vaccines against redwater [18]. Passage may also result 
in selection of additional phenotypes such as inability of 
transmittance by ticks or loss of efficacy [19–21]. In some 
cases, reversion to virulence has been observed, even in 
non-tick transmissible strains [18, 20]. These phenotypic 
transformations may be due to parasite subpopulations 
with varying virulence or tick-transmissibility, selected 
during serial blood passage, or even genetic changes in 
clonal parasite populations [19]. Since all vaccine stocks 
derive from regional specific parasite populations that 
was selected through serial passage bottlenecks [15], it 
may be expected that each geographical vaccine stock 
may present unique genetic makeups and phenotypic 
properties obtained via a stochastic process. Dissection 
of the genetic makeup of these passaged vaccine stocks 
may therefore illuminate characters responsible for vari-
ous phenotypes, or shared in efficacious vaccines.
In South Africa, a virulent B. bovis S strain was rapidly 
syringe passaged ten times in splenectomized calves to 
yield the S10 strain [22, 23]. The S10 strain was less viru-
lent than the original S strain and was used from 1978 as 
the S11 passage. However, severe reactions in calves still 
occurred, leading to an additional thirteen rapid syringe 
passages through splenectomized calves to obtain the 
S23 strain [21]. This strain retained efficacy, but was less 
virulent than S11 and has been used in the commercial 
vaccine as S24 since 1981 [21]. The S24 vaccine strain is 
non-transmissible in ticks, limiting its potential to revert 
to virulence or spreading disease through transmission 
[21, 24]. More recently, its non-transmissibility was con-
firmed, but it was shown that co-transmission is possi-
ble when an animal is infected with additional B. bovis 
strains, such as the 05-100 field strain [21]. This has also 
been observed for Australian B. bovis vaccine strains that 
was rapid passaged for 20–30 times, that still contained 
transmissible and non-transmissible clones [19, 20]. This 
suggested that transmissible subpopulations may support 
non-transmissible subpopulations by providing transmis-
sion factors either exogenously, or via sexual recombina-
tion. It also suggested that the South African S24 vaccine 
strain is probably a clonal strain that lacks any transmis-
sible subpopulations [21].
Dissection of the genetic makeup of the S24 vaccine 
strain using the Bv80 gene showed that the genetic com-
position of the vaccine changed over time from the S11 
to the final S24 strain [25]. This was related to a change 
in B. bovis population complexity and makeup during the 
rapid syringe passages in splenectomized cattle. The S11 
strain possessed both A and B Bv80 alleles of A645 and 
B585, respectively, while the S24 strain only possessed 
a single A allele of A558 (the prefix A or B denote the A 
or B allele of the Bv80 gene, while the size of the band is 
indicated in base pairs) [25]. This previous study indicated 
a marked change in allele populations between passage 
S16 (S11 profile) and passage S18 (S24 profile), indicating 
a changeover in populations within one or two passages. 
The present study investigated this B. bovis population 
change in more depth to determine whether selection 
of the S24 allele was a random event, or whether condi-
tions during passages affected the dramatic change from 
dominant A645 and B585 populations to the single A558 
genotype observed in S24. In addition, genome sequenc-
ing was used to show that sexual recombination occurs 
during co-transmission of the S24 and 05-100 field strain.
Methods
Animals
Cattle used for vaccine serial passage (n = 2; 8-month-
old), transmission (n = 14; ≥ 5-year-old) and cloning 
(n = 8; 9- to 15-month-old) studies were all fully sus-
ceptible splenectomized Herefords, reared and kept 
from birth under tick free quarantine conditions at the 
ARC-OVR.
Tick vector
A colony of uninfected R. (B.) microplus larvae main-
tained at the ARC-OVR were used for the experimental 
infection of adult females with B. bovis and subsequent 
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transmission feeding of the larval progeny on susceptible 
splenectomized animals. Replete females that dropped 
from the uninfected control and infected animals were 
kept at 24 °C and 75% relative humidity with a circadian 
day and night cycle of 12  h. The hemolymph of these 
ticks was examined for B. bovis kinetes from which the 
infection rate per tick batch were determined (number 
of infected ticks divided by n = 20 ticks examined per 
batch, expressed as %). For the transmission attempts, 
each bovine received the progeny of 1g (± 20,000) larvae, 
pooled from 15 females that were distributed on the back 
line of cattle allowing for natural unrestricted movement 
on the animal’s body to the preferred sites of attachment 
for this species.
Passaging of vaccine strains
The B. bovis S16 vaccine stabilate used for intravenous 
serial passage was from the 1981 deep frozen stock con-
taining ± 2.7 × 108 parasites/ampoule at time of freezing. 
To distinguish between the numbering of original unfro-
zen serial passaging (S12 to S22) and revival passaging 
with frozen S16 material, the suffix ‟.2” was added to the 
generation number. Infected S17.2 blood was collected 
for cloning by limiting dilution and PCR study in ethyl-
enediaminetetraacetic acid (EDTA), for serial passaging 
in acid-citrate-dextrose (ACD) anticoagulant (2.16 × 108 
parasites/ml) and for deep freezing using dimethyl sulfox-
ide (DMSO) as cryoprotectant. Blood for serial passaging 
was kept for 7 days at 4 °C (simulating the original proce-
dure followed during unfrozen serial passaging from S11 
to S22), where after 5 ml was administered intravenously 
to a bovine and from which at the peak of the reaction 
S18.2 infected blood were collected for PCR.
Cloning by limiting dilution
For cloning by limiting dilution, fresh B. bovis S17.2 para-
site infected blood was collected at the peak of the ani-
mal’s reaction. The number of parasites per ml blood was 
determined (percentage of infected red blood cells mul-
tiplied by the number of red blood cells per ml of blood) 
and uninfected donor blood was used to dilute the blood 
to theoretically contain 3 parasites in 4 ml (Table 2) [21]. 
Eight cattle were each inoculated intravenously with 4 
ml of the dilution within five hours after collection of 
the infected blood from the donor animal. Animals were 
monitored 30 days for infection. Blood for PCR tests and 
cryopreservation of clonal lines was collected in EDTA 
during the acute stage of animal reactions, or after 30 
days for non-reactors. One of the clonal lines obtained, 
9526-17.2-cl (genotypic similar to the Bv80 A558 popula-
tion found in the S24 vaccine) were selected for further 
tick infection and transmission study (Table  1). Clonal 
line designations refer to the animal used indicated by its 
unique number (9526), the origin of the isolate (S17.2) 
and its clonal nature (cl).
Strains and clonal line used for tick pick‑up
Babesia bovis vaccine used for tick infection by R. (B.) 
microplus were from the frozen stabilates of S16 and 
S17.2 and were administered intravenously to 2 individ-
ual animals each at doses containing 2.5 × 107 and 5 × 107 
parasites, respectively. The clonal line 9526-17.2-cl used 
was from frozen stock and administered intravenously to 
2 animals at 5 × 107 parasites per single dose (Table  1). 
Animals were infected at such a time as to ensure that 
the presence of engorging adult females coincided with 
the parasitaemic period for the specific inoculum. Once 
replete, dropped off ticks were collected, sorted accord-
ing to inoculum and the larvae used for transmission 
study.
Monitoring infections
Cattle were monitored daily (30 days) for rectal tempera-
tures, packed cell volumes (PCV) and Giemsa stained 
blood smears. Infectivity in cattle was determined by 
demonstrating the B. bovis parasites in stained blood 
smears. Tick infection rate, expressed as percentage posi-
tive, was determined by demonstrating B. bovis kinetes in 
hemolymph smears prepared from 20 females that were 
randomly selected on day 10 of the oviposition period. 
EDTA-blood was collected during the clinical reaction 
as well as weekly for the 30-day period for analysis using 
PCR.
PCR and analysis of genotypes
EDTA-blood (200  μl) was extracted using the Mag-
NAPure LC (Roche) and DNA eluted into 100  μl elu-
tion buffer (50 mM Tris-HCl, pH 8.0) as described [26]. 
All samples were confirmed negative for B. bigemina by 
PCR amplification using primers specific for B. bigemina 
(BBIA: 5′-CAT CTA ATT TCT CTC CAT ACC CCT 
CC-3′; BBIB: 5′-CCT CGG CTT CAA CTC TGA TGC 
CAA AG-3′) [27]. Genotypes were analyzed using the 
Bv80 allele specific primers for allele A (BbAF: 5′-GTA 
GTG GAG CCC ACT GAA GAG CCG GCT GGC-3′; 
BbAR: 5′-GCC ACA TTT GGG TAC AAG ATT ACA 
AGA AGC-3′) and allele B (BbBF: 5′-GAG CAG CCA 
GTT GCT GAA GAA CCA TCT GAT-3′; BbBR: 5′-TTC 
ACC TTT GCG ACC ACC GTA ACA AGG TCT-3′) 
[25]. Amplification was performed using a touch-down 
procedure that included an initial denaturation at 95  °C 
(2 min) followed by denaturation at 95 °C (30 s), anneal-
ing at 65–55 °C (30 s), extension at 72 °C (2 min) for 10 
cycles, followed by 40 cycles using an annealing tem-
perature of 55  °C. The High Resolution Cartridge of 
the QIAxcell system (Qiagen, Hilden, Germany) [28] 
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was used to analyze the samples. As standard, the 100 
bp O’Gene Ruler ladder was used (Fermentas, Vilnius, 
Lithuania) and the peaks integrated using the QIAxcell 
software.
Isolates selected for genome sequencing
Isolates selected for genome sequencing included three 
clones obtained from the S17.2 limiting dilution, namely 
9622-S17.2cl (A558), 9623-S17.2cl (A535) and 9626-
S17.cl (A558). In addition, the S24 vaccine isolate was 
sequenced (9512-S24) and the 05-100 field strain (9547-
05-100). The latter strain possesses a single B615 allele 
for Bv80 and enabled co-transmission of the S24 vaccine 
strain previously [21, 25]. Three clones obtained by limit-
ing dilution of the co-transmitted S24 and 05-100 strains, 
namely 9480-S24×05-100, 9574-S24×05-100 and 9563-
S24×05-100 were also sequenced to detect possible sex-
ual recombination between S24 and 05-100.
Genome sequencing using Illumina HiSeq
Blood was sampled (100 ml), from infected animals into 
EDTA tubes and red blood cells washed five times by 
pelleting at 845×g for 10  min, removing the superna-
tant and buffy coat layer and resuspending in an equal 
volume of phosphate buffered saline (PBS). The remain-
ing red blood cells were resuspended in an equal vol-
ume of water and passed through a cellulose column 
to remove bovine lymphocytes [29]. The flow through 
was used for genomic DNA extraction using the Roche 
MagNA Pure system as described [30]. Genomic DNA 
was submitted to the Biotechnology Platform Next Gen-
eration Sequencing Service of the Agricultural Research 
Council (Onderstepoort, South Africa). Samples were 
processed using Nextera DNA preparation kits (Illumina, 
San Diego, CA, USA) and sequenced using the Illumina 
HiSeq 2500 sequencer.
Raw paired Illumina reads were quality trimmed using 
the BBDuk (Bestus Bioinformatics Decontamination 
Using Kmers) program in the BBTools (Bestus Bioinfor-
matics Tools) suite (https ://jgi.doe.gov/data-and-tools /
bbtoo ls/). For trimming, a single base pair was removed 
from each read and then Nextera and Illumina adapt-
ers were removed using specified parameters (ktrim = r, 
k = 21, mink = 11, hdist = 2, tpe, tbo) using the BBDukF 
command. PhiX contamination was then removed using 
the same command with specified parameters (k = 31, 
hdist = 1). Paired reads were quality trimmed to Q20 
using specified parameters (qtrim = r, trimq = 20), reads 
with quality below 20 were discarded (maq = 20) and 
reads below 50 bp were removed (qtrim = r, trimq = 10, 
minlen = 50). Reads were then normalized using the 
BBNorm program, to either an average depth of 100× 
(discarding reads with coverage below 20) or an average 
depth of 50× (discarding reads with coverage below 10), 
depending on the amount of sequence data generated ini-
tially. Quality trimmed and normalized paired sequence 
datasets were then used for assembly. Assemblies were 
performed using the CLC Genomics Workbench v 11 
software (Qiagen). Reads were de novo assembled using 
standard assembly parameters: mismatch cost-2, inser-
tion cost-3, deletion cost-3, length fraction-0.5, similar-
ity-0.9, minimum contig length-200, automatic bubble 
size and a variable word size (kmers). For each sample a 
range of assemblies with different kmers (64, 60, 55, 50, 
Table 1 Rhipicephalus (B.) microplus transmission of the B. bovis S17.2 and S18.2 vaccine strains, and the S17.2 clonal line parasite 
population
a Stabilate used for infection
Group B. bovis strains B. bovis Bv80 
genotype 
classification 
according to 
alleles and base 
pairs
No. of cattle 
used for tick 
feeding
Parasitaemia 
during dropping 
of engorged 
females (%)
Percentage female 
ticks hemolymph 
positive for 
kinetes out of 20 
examined
No. of cattle 
each infested 
with ± 20,000 
larvae
B. bovis genotype(s) 
detected following 
transmission
1 S17.2 (S16)a A558; A627; A645; 
B585
2 0.20–1.5 95 1 A558; A627; A645; 
B585
0.08–1.0 100 1 A558; A627; A645; 
B585
2 S18.2 (S17.2)a A645; B585 2 0.60–1.7 100 1 A645; B585
0.20–1.2 50 1 A645; B585
3 Not infected – 1 – 0 1 No transmission
4 9626-S17.2-cl 
(originating from 
3 parasites of 
S17.2)a
A558 2 0.10–1.0; 0.09–0.8 0; 0 1; 1 No transmission
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45, 40, 35, 30, 25, 20 and 15) were performed. Assem-
bled contigs were extracted, compared to the refer-
ence genome using BLASTN analysis and chromosome 
specific contigs mapped to the reference genome [31], 
to produce a final assembled genome scaffold for each 
sample from which consensus genome sequences were 
derived. Parameters from the different assemblies and 
coverage may be accessed in Additional file 1: Table S1, 
Additional file 2: Table S2 and Additional file 3: Table S3.
Genome comparisons
To compare genomes, they were partitioned into 1000 bp 
fragments and compared to other assembled genomes 
using BLASTN analysis to obtain both pairwise identities 
and size of the longest aligned hit [32]. This was plotted 
across the genome length to assess potential recombina-
tion. Assembled genomes were also aligned using Mauve 
with default parameters [33]. Gaps were removed from 
the alignment using GBlocks [34], to enable manual 
inspection for recombination cross-over and phyloge-
netic analysis.
Phylogenetic analysis
To determine relationships of the various sequenced 
clonal lines, the aligned genomes were analyzed by Maxi-
mum Likelihood analysis using IQ-Tree v1.5.2 [35]. Opti-
mal substitution models were estimated for each aligned 
chromosome partition: Chr1a + b (TVM + I + G4), 
Chr2 (TVM + I + G4), Chr3 (TVM + I), Chr4a, Chr4b 
(TVM + I + G4). An edge-proportional partition model 
with proportional branch lengths (-spp) was used to 
allow each partition its own specific rate to accommo-
date different evolutionary rates between partitions. 
Nodal support was estimated using ultrafast bootstrap 
(n = 100,000) and the 50% consensus tree was reported. 
The number of sites used in the analysis was 6,629,566 
sites.
Variant detection within and between genome datasets
Genetic diversity within and between genome datasets 
were investigated by mapping datasets to the respective 
consensus genomes obtained for the various clonal lines 
using CLC Genomics Workbench v 11 software (Qiagen). 
Parameters for mapping were match score 1, mismatch 
cost 2, insertion cost 3, deletion cost 3, length fraction 0.5 
and similarity fraction 0.9. Parameters for basic variant 
detection were ploidy 1, exclusion of positions with cov-
erage 2× above the average genome coverage and exclu-
sion of broken pairs. Positions were considered with a 
minimum coverage of 10, minimum read count of 10 and 
50% frequency.
Results
Transmission of S16 and S17.2 vaccine strains
The genetic makeup of the S16 passage was similar to 
previous work [25], indicating a major A645 allele and a 
major B585 allele (Fig. 1). Infection by needle challenge 
to produce the S17.2 strain resulted in the appearance of 
the A558, A627 and A645 genotypes, as well as the B585 
genotype (Fig.  1). Tick pickup (Group 1) resulted in a 
high infection rate (95% and 100%, n = 20 each) and tick 
transmission recovered all alleles in two separate trans-
mission events (Fig.  1, Table  1). Admittedly, the A558 
allele was almost non-detectable for either transmission. 
A single passage from S17.2 that yielded the S18.2 strain 
resulted in loss of both A558 and A627 alleles, with only 
the A645 and B585 alleles remaining. Tick pickup (Group 
2) resulted in infections rates of 100% and 50% (n = 20 
each) with transmission of both alleles (Fig.  1, Table  1). 
Ticks (n = 20) collected from the uninfected control ani-
mal (Group 3) showed no kinetes in the haemolymph 
after feeding and no parasites were demonstrated in the 
animal used for transmission feeding (Table 1).
Clonal lines obtained from the S17.2 vaccine strain
Since the A558 allele was lost during passage of the S17.2 
strain, limiting dilution of this latter strain was attempted 
to recover this allele. Infection of splenectomized cattle 
(n = 8) with limiting dilution inoculums (theoretically 
containing 3 parasites), yielded four A558 clones similar 
to that found in the S24 vaccine and two clones of A535 
not previously observed (Table 2).
Transmission of S17.2‑cl
A single clone, 9626-S17.2-cl (A558) of the six B. bovis 
clonal lines obtained by limiting dilution of S17.2 were 
selected for further transmission studies (Table  1). This 
parasite clonal line (Group 4) failed to infect ticks in 
2 feeding attempts and could not be transmitted to 2 
susceptible bovines. No kinetes were demonstrated in 
the hemolymph of both tick batches (n = 20) used for 
infection.
Genomic comparisons of S17.2‑cl, S24 and crosses 
with the 05‑100 field strain
Previous attempts to recover the S24 vaccine strain by 
limiting dilution failed on numerous occasions [21]. The 
question was therefore raised regarding the relationship 
of the A558 genotypes from the S16 and the S24 passages, 
since they exhibit different limiting dilution phenotypes 
(ability to proliferate after limiting dilution vs the inabil-
ity to proliferate), even if both were non-transmissible 
and exhibit the same A558 genotype. To address this, the 
genomes of three S17.2-cl clones (9622-S17.2cl [A558], 
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9626-S17.2cl [A558]; 9623-S17.2cl [A535]) as well as the 
S24 vaccine strain were sequenced. Genomes were de 
novo assembled and contigs scaffolded onto the reference 
genome resulting in assemblies that represented > 90% 
of the major chromosomes of the original Texas T2Bo B. 
bovis genome (chromosomes 1a, 1b, 2, 3, 4a and 4b) [31]. 
Average coverage ranged from 31 to 169 (Fig.  2, Addi-
tional files 1, 2, 3: Tables S1, S2, S3) and was even across 
the major chromosomes for each assembled genome, sug-
gesting that all regions are well represented in the final 
assemblies (Fig. 2).
Sequence comparison of 9622-S17.2-cl (A558), 
9626-S17.2-cl (A558) and 9512-S24 (A558) over a com-
bined length of 6.5-6.9 Mbp (alignment of Chr1a, Chr1b, 
Chr2, Chr3, Chr4a and Chr4b, with gaps removed), indi-
cated 100% identity (Fig. 3). This combined length repre-
sents 80–85% of the original T2Bo genome and indicate 
that the A558 bp genotypes from the S16 and S24 pas-
sages derive from the same parasite population. While 
several truncated or fragmented genes exist between 
the genomes that may explain the limiting dilution phe-
notypic differences, these may be due to assembly arte-
facts and need further investigation. Interestingly, clone 
9623-S17.2-cl (A535) also show 100% identity to S24 
(A558) over a combined length of 6.7 Mbp that represents 
83% of the original B. bovis genome. It suggests that A535 
also derive from the S24 ancestral population and that 
genetic changes can occur within the time course of sev-
eral passages. This is supported by phylogenetic analysis 
based on whole genome alignment of 6,629,566 sites that 
indicated that 9622-17.2-cl, 9623-17.2-cl, 9626-17.2-cl 
and 9512-S24 group in a well-supported clade with small 
intra-clade genetic distances (Fig. 4), suggesting very close 
genetic relationships as may be expected if these derived 
from the same ancestral population. Conversely, compari-
son to field strain 9547-05-100 (B615), previously used in 
a co-transmission study [21], indicated that the average 
identity was ~97% compared to S24 (A558), while 100% 
identity was only observed for a combined length of 1.3 
Mbp, comprising 16% of the original T2Bo genome length 
distributed homogenously throughout the genome. This 
would suggest a closer genetic relationship between the 
vaccine derived clones compared to the field strain. This is 
supported by phylogenetic analysis that indicated that the 
vaccine and field strains group in different clades (Fig. 4).
Tick transmissibility and sexual recombination
Both S17.2-cl and S24 failed to infect ticks and transmit 
in a clonal genotype state. However, co-transmissibility 
was observed for both in the presence of other trans-
missible genotypes in this and previous studies [21]. A 
number of possible reasons were previously proposed 
for non-transmissibility/transmissibility and rescue dur-
ing co-transmissibility [21]. One reason proposed was 
sexual recombination that allows tick transmittance fac-
tors to be acquired by non-transmissible genotypes. 
To assess the possibility that S24 and 05-100 sexually 
recombined before tick transmission, the genomes from 
9512-S24, 9547-05-100 and the clones (9480-S24×05-
100, 9563-S24×05-100, 9574-S24×05-100) previously 
obtained via limiting dilution [21], was compared. Pair-
wise sequence comparison of 9512-S24 and 9547-05-100 
showed an average sequence identity of 97.2% across 
7.1 Mbp, homogenously distributed throughout the 
genome (Fig. 3). It should therefore be possible to detect 
recombination events by pairwise comparison to iden-
tify regions that show 100% identity to either 9512-S24 
or 9547-05-100 in the clones sequenced. Comparison of 
9563-S24×05-100 and 9574-S24×05-100 with 9512-S24 
and 9547-05-100 indicated average sequence identities 
of 97% and 99%, respectively (Fig.  5). This can also be 
observed in the random distribution of fragments with 
100% identity compared to 9512-S24 that only cover a 
combined length of 1.1–1.2 Mbp, while comparison with 
9547-05-100 gave a combined length of 5.4–5.8 Mbp vis-
ible as long continuous stretches (Fig.  5). Clones 9563-
S24×05-100 and 9574-S24×05-100 are not considered 
to display any recombination signals with 9512-S24. 
Phylogenetic analysis do suggest that 9563-S24×05-100 
and 9574-S24×05-100 may be divergent lineages from 
05-100, or that they are S24×05-100 recombinants with 
very little recombination signal from S24, with the major 
parent being 05-100 (Fig. 4). Even so, 9547-05-100, 9563-
S24×05-100 and 9574-S24×05-100 group within a well-
supported clade suggesting a shared genetic relationship.
Conversely, comparison of 9480-S24×05-100 with 
9512-S24 and 9547-05-100 indicate average sequence 
identities of 98.7% and 98.0%, respectively (Fig. 5). Frag-
ments of 100% identity cover a combined length of 4.7 
Mbp (66% combined length) and 3.0 Mbp (42% combined 
length) when compared to 9512-S24 and 9547-05-100, 
respectively. Visual comparison clearly shows alternat-
ing stretches of 100% identity between 9512-S24 and 
9547-05-100 that covers a larger proportion of 9512-S24. 
Compared to the profiles obtained for 9563-S24×05-100 
and 9574-S24×05-100, this suggests that 9480-S24×05-
100 represent a recombination event between S24 and 
05-100. Five major cross-over events may be identified 
that occurred on chromosome 1 (~0.075 Mbp for 9574-
05-100; ~0.72 Mb for 9512-S24), chromosome 2 (~0.99 
Mbp for 9547-05-100; ~0.61 Mbp for 9512-S24), chro-
mosome 3 (~1.37 Mbp for 9547-05-100; ~1.1 Mbp for 
9512-S24), chromosome 4a (~0.64 Mb for 9547-05-100; 
~1.13 Mbp for 9512-S24) and an undefined locality that 
occurred between chromosome 4a and chromosome 
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Fig. 1 Analysis of the Bv80 alleles for various passages. Indicated are the sizes found for either allele A or allele B as well as the identity of the 
isolates or clonal lines
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4b resulting in chromosome 4b corresponding with 
9512-S24 (~0.74 Mbp). These cross-over events were 
confirmed by manual inspection of genome sequence 
alignments of 9512-S24, 9547-05-100 and 9480-S24×05-
100. Phylogenetic analyses also indicated that 9480-
S24×05-100 group between the S24 and 05-100 clades, 
as may be expected if it shares similarity to both parent 
strains, namely S24 and 05-100 (Fig. 4).
Variation within and between genomic datasets
The question is raised whether the 9512-S24 vaccine 
strain, 9547-05-100 field strain and various clonal limit-
ing dilution lines and the proposed recombinant clone 
9480-S24×05-100 are indeed clonal lines and not con-
taminated with other genotypes. To address this, genetic 
variation was assessed by variant calling of each dataset 
to itself. This resulted in variation of ~0.1% or less within 
single datasets (Fig.  6). Those clonal lines (9622-17.2-cl, 
9623-17.2-cl, 9626-17.2-cl) proposed to derive from the 
ancestral 9512-S24 population also showed less than 0.1% 
variation within their own datasets and compared to the 
9512-S24 dataset (Fig. 6), supporting a common ancestry 
as suggested by phylogenetic analysis.
The clonal lines for which no recombination was 
detected (9563-S24×05-100 and 9574-S24×05-100), 
implying that they derived from recombination of 05-100 
with itself, showed ~0.1% or less variation within their 
own datasets (Fig. 6). Even so, they do show higher vari-
ant percentages compared to 9547-05-100 as suggested 
by phylogenetic analysis as well, suggesting that while 
deriving from a common ancestral population, may be 
divergent from 05-100.
A simulation of mixed populations using combined 
datasets for 9512-S24 and 9547-05-100, mapped against 
the various assembled genomes resulted in much 
higher percentages of variation (0.3–2.2%) (Fig.  6). 
This is the signature expected for mixed populations 
and contrast to the similar levels of genetic diversity 
observed for all single datasets, suggesting that the 
genomes assembled do derive from clonal or dominant 
populations. The recombinant clone in the study, 9480-
S24×05-100 shows levels of variation intermediate 
between single and simulation sets when compared to 
either 9512-S24 or 9547-05-100, suggesting again that 
it shared combined signals as may be expected for a 
recombinant clone.
Discussion
Attenuation of live parasite cultures is a well-accepted 
approach to develop vaccines using whole organisms 
[15]. It generally entails repeated passage in live animals 
or cell culture to select for populations that are less viru-
lent than the original strain. However, the attenuation 
process itself is not well understood and remain a sto-
chastic process that introduce significant uncertainty into 
the process of vaccine production. Attenuation may be 
due to selection of less virulent populations, decrease in 
the genetic diversity of a parasite population or genetic 
changes within a population [18, 36]. It implies that 
attenuation is multifactorial and that attenuation of inde-
pendent strains may not necessarily result in vaccines 
with similar genetic compositions. It also raises the inter-
esting question whether attenuation of a specific virulent 
isolate is repeatable. In the present study this topic was 
investigated by revisiting the attenuation process of the 
South African S24 vaccine strain.
The S24 vaccine strain is characterized by a clonal pop-
ulation that exhibits the Bv80 A558 genotype [25]. Pre-
viously, this genotype was observed to appear between 
rapid syringe passage 16 and 18 of the original S11 vac-
cine strain, with a dramatic loss of the A645 and B585 
genotypes. In an attempt to reconstruct this changeover 
in the vaccine composition, the original S16 frozen stock 
was used to generate S17.2 infection. This resulted in the 
appearance of the expected A558 genotype observed in 
the current S24 vaccine. It was also accompanied by a 
reduction in the signal for the A645 genotype. However, 
the B585 genotype was not reduced. Subsequent pas-
sage to generate a S18.2 strain did not result in further 
increase of the A558 genotype, but the passage reverted 
back to the genetic profile observed for the S16 passage, 
i.e. a strong signal for the A645 and B585. This suggests 
that while the appearance of the A558 genotype could be 
confirmed, the changeover in population structure could 
not be reproduced. It also suggests that creation of the 
current South African S24 vaccine strain was a serendipi-
tous event, underscoring the genetic importance of this 
clonal line as National Asset, since recent studies con-
firmed its efficacy [37].
Part of the original protocol was the continuous pas-
sage of live parasites without any freezing steps between 
passages. The S17.2 strain from the present study was 
Table 2 Cloning by limiting dilution of the B. bovis S17.2 vaccine 
strain for group 1 (Table 1)
a Percentage of cattle that became infected in parentheses
Bv80 genotype 
classification 
according to 
alleles and base 
pairs
Theoretical no. of 
B. bovis parasites 
in 4 ml inoculum
No. of 
splenectomized 
cattle inoculated
No. of single 
genotype 
clonal lines 
obtained 
by limiting 
dilution
A535 A558
A558; A627 3 8 2 (25)a 4 (50)a
A645; B585
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Fig. 2 Coverage of the various assembled B. bovis genomes for the major chromosomes (Chr1a, Chr1b, Chr2, Chr3, Chr4a, Chr4b) concatenated 
together. Included is the overall average coverage
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derived from a frozen S16 stock that has been maintained 
at −70 °C for 36 years. Whether this impacted on the ina-
bility of the A558 genotype to reestablish itself as domi-
nant genotype is not known. It is considered that rapid 
passage may select for fast replicating populations result-
ing in loss of slow replicating populations. The absence of 
the tick transmitting genotype in some attenuated strains 
may support this, since these genotypes may lack cer-
tain genomic regions associated with tick transmission, 
resulting in smaller genome sizes or factors that impact 
on replication rate.
Remarkably, cloning by limiting dilution of the S17.2 
strain resulted in the complete loss of both major geno-
types (A645 and B585), with recovery of 50% of animals 
(n = 4) infected with the A558 genotype and 25% animals 
(n = 2) infected with a completely novel A535 genotype. 
This suggests that these genotypes may be prone to sur-
vival at very low parasitaemia, or less likely to be identi-
fied and removed by the splenectomized host’s immune 
system, or be sequestered in the host compared to the 
dominant genotypes. In this regard, the original storage 
of blood for 7 days at 4  °C prior to passage from S11 to 
S22 may have contributed towards the selection of the 
A558 genotype and loss of the A645 and B585 geno-
types that resulted in lower numbers of parasites surviv-
ing between passages. Recovery of the A558 genotype 
by limiting dilution from S17.2, suggests alternative 
approaches to attain attenuation, by selection of defined 
Fig. 3 Comparison of assembled genomes from the S17.2-cl clonal lines 9622-S17.2-cl, 9623-S17.2-cl, 9626-S17.2-cl as well as the field isolate 
9547-05-100 with 9512-S24. Indicated are pairwise sequence comparisons of 1000 bp fragments from 9512-S24 against various genomes. 
Percentage identity values for these fragments were sorted from low to high percentage and plotted against the combined length of the genome. 
The average pairwise identity of all fragments (n = 7640 ± SD) are also indicated
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clonal populations. This may be a viable approach if the 
current S24 vaccine strain should be lost by mishap.
Attempts to recover the S24 vaccine strain using lim-
iting dilution previously failed on 34 attempts [21]. It is 
therefore quite surprising that the majority of genotypes 
recovered in the present study were for the A558 geno-
type. This may indicate that multiple A558 genotypes 
existed and that the S17.2 strains are different from the 
S24 vaccine strains. It may also suggest that the S24 A558 
genotype underwent a significant genetic change during 
passage that may have included loss of tick transmissibil-
ity, loss of virulence and loss of ability to propagate after 
limiting dilution. In this regard, virulence and limiting 
dilution phenotypes have been linked before [38]. Given 
the high genetic similarity observed between the S24 and 
S17.2 genomes, it suggests that loss of virulence and lim-
iting dilution phenotypes may be restricted to only few 
genes in the genome.
The present study again confirmed the non-transmis-
sibility of the A558 genotype when present as a clonal 
population. Interestingly, its presence in the S17.2 strain 
did not result in significant co-transmission with the 
A645 and B585 genotypes. This may suggest that the 
Fig. 4 Maximum Likelihood analysis of the various Babesia genomes. 
Total sites used were 6,629,566 sites with all gaps removed. Bootstrap 
support (n = 100,000) are indicated and the 50% consensus tree 
presented. The tree was rooted with the T2Bo genome
Fig. 5 Potential recombination between S24 and 05-100. Indicated are the pairwise sequence comparisons (1 kb window across genome) of 
the S17.2-cl clones 9480-S24×05-100, 9563-S24×05-100 and 9574-S24×05-100 obtained from the co-transmission of S24 and 05-100 with 
9512-S24 and 9547-05-100. Only regions of 100% identity are indicated by black lines. The average sequence identity is indicated on the right for 
each sequence pair and the corresponding regions for the major chromosomes are indicated on top. Crossover points due to chromosomes are 
indicated with dotted X’es while recombination events are indicated by solid X’es and the total recombination events by solid circles. Various genes 
are indicated by their respective symbols
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levels of parasitaemia were not high enough to ensure co-
transmission, which would correlate with its inability to 
appear in the S18.2 passage.
The present study attempted to reconstruct the events 
that led to replacement of the original dominant A645 
and B585 genotypes found in the S16 passage, with the 
A558 genotype present in the S18 passage that was even-
tually used as the commercial vaccine at passage S24. 
While the A558 genotype was observed in passage S17.2, 
it failed to replace either A645 or B585 genotypes in the 
subsequent S18.2 passage. This suggests that passage 
from frozen stocks may not necessarily recapitulate his-
torical passages.
The limiting dilution phenotype has previously been 
linked to cytoadherence and the ability to evade the 
host’s immune system [18, 38]. This has been linked to 
various potential genes, notably the variant erythrocyte 
surface antigen (VESA1) family, the small open read-
ing frame (smORF) family and the spherical body pro-
tein (SBP2) family [38–41]. In the regions identified 
as potential recombined regions in 9480-S24×05-100 
that derive from 05-100 there is 19 VES, 9 smORF and 
2 SBP2 genes on chromosome 2 and 11 VES, 4 smORF 
and 11 SBP2 genes on chromosome 3 and none of these 
genes on chromosome 1 or chromosome 4a. These genes 
could potentially be involved in the limiting phenotype 
observed for 9480-S24×05-100.
The inability to obtain the A558 genotype during lim-
iting dilution of S24 may suggest that the limiting dilu-
tion phenotype is genetically linked with the Bv80 gene 
(genetic proximity). Conversely, it would also suggest 
that the tick-transmissible and limiting dilution phe-
notypes are not genetically linked since the S16 vaccine 
strains that possessed the A558 allele exhibited the lim-
iting dilution phenotype, although it could not be tick-
transmitted. More work is however, required to confirm 
these possibilities. The regions identified as potential 
recombined regions in 9480-S24-05-100 that derive from 
05-100 contain ~438 genes on chromosome 2, ~620 
genes on chromosome 3 and ~290 genes on chromosome 
4a. Of these, 68 are coding for potential membrane pro-
teins that may act as receptors for gut invasion [31].
The molecular basis for tick transmission phenotypes 
has not been elucidated yet, given the various possibilities 
Fig. 6 Assessment of variants within genomic datasets, between datasets and simulation of mixed populations within a dataset. Datasets (top 
animal number) were mapped to genomes of bottom animal numbers and variant calling was performed to assess genetic variation within the 
dataset. For simulation of mixed populations two datasets from 9512-S24 and 9547-05-100 were combined and mapped to various genomes
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that exist which will result in a tick transmission or non-
transmission phenotype. This may include inability to 
penetrate tick gut, salivary gland or ovary cells due to 
an absent/dysfunctional parasite receptor. Alternately, 
transmissible parasites secrete an enzyme in the tick gut 
that enables all parasites to penetrate the gut epithelium, 
even though absent in some genotypes [20]. Non-trans-
missible strains may acquire the enzyme during sexual 
recombination. The tick immune system may be able to 
kill non-transmissible strains [42–44]. In this case genes 
involved in tick immune responses would be absent from 
the non-transmissible strains. Tick-transmissible parasites 
may upregulate host proteins involved in parasite inva-
sion [42]. Non-transmissible strains would lack the genes 
involved in host upregulation. In all of the above scenar-
ios parasite genes are absent in non-transmissible strains 
and the A558 genotypes would have acquired the parasite 
receptor or protein involved in tick transmission through 
sexual recombination [19, 45]. Other possibilities may 
include differential gene expression in different parasite 
strains. Future experiments may include transcriptome 
analysis to determine whether gene expression differences 
could be linked with the non-transmissible phenotype.
Another possibility would be that genes involved in devel-
opment of the sexual stage in the tick are responsible for the 
non-transmissible phenotype of S24. These may include the 
6-Cys gene superfamily (A-J) or the hap2 gene [46, 47]. This, 
however, seems a remote possibility since the 6-Cys genes 
are intact in all sequenced genomes and in recombinant 
9480-S24×05-100 all derive from the S24 strain. In recom-
binant 9480-S24-05-100, hap2 derive from 05-100 and may 
contribute to the tick transmissibility phenotype in recom-
binant 9480-S24-05-100. However, hap2 are also intact in 
all genomes sequenced including 9512-S24 suggesting that 
it would be functional in the S24 strain. Given that 9480-
S24×05-100 derive partly from S24, it suggests that the S24 
vaccine strain is capable of sexual recombination.
Sexual recombination has been accepted as part of 
the life-cycle of Babesia parasites [48]. Development of 
blood stage merozoites to gametocytes, division to gam-
etes after tick ingestion, sexual recombination by haploid 
gametes to form diploid zygotes that infect the gut as 
ookinetes, with subsequent division into haploid kinetes 
inside the gut epithelium [48], has been well documented 
using light and electron microscopy [49, 50]. The hap-
loid nature of merozoites and gametes and the diploid 
nature of the zygote has been demonstrated using flow 
cytometry [51], indicating sexual fusion. This seems 
to be a general feature of all protists [52]. However, to 
date no genetic data have confirmed sexual recombina-
tion in B. bovis, although sexual recombination could be 
expected given its occurrence in other Piroplasmida such 
as Theileria [53]. The present study confirmed sexual 
recombination in B. bovis using genetic data that show a 
clonal line obtained after co-transmission sharing signifi-
cant stretches of identity with either parental strain.
A low cross-over frequency was found compared to 
other protozoan parasites such as Plasmodium falciparum 
[54] and Theileria parva [55]. However, the number satis-
fies the obligatory number of crossover events necessary 
for successful meiosis and falls well within the average of 
1–2 crossover events per chromosome observed for many 
organisms [56]. The low number may be explained by the 
clonal population that was analyzed and would reflect the 
recombination history of a single clone, rather than that of 
a population. However, the purpose of the present study was 
not the fine mapping of recombination, but to identify in a 
broad sense possible genomic regions that may be involved 
with the tick transmissible and limiting dilution phenotypes.
Conclusions
The present study investigated the development of 
the current S24 vaccine and showed that its selection 
during rapid passage was a serendipitous event. The 
resulting vaccine showed both non-transmissible and 
lack of limiting dilution phenotypes, the latter possibly 
responsible for its attenuation. It confirmed its inability 
to be tick transmitted and showed that sexual recombi-
nation is probably responsible for tick co-transmission. 
To our knowledge, this is also the first genetic evidence 
of sexual recombination for Babesia bovis. Progressive 
crossing of 05-100 recombinant lineages with the S24 
vaccine stock, using the tick transmission and limiting 
dilution phenotypes as selection criteria may result in 
identification of the genes responsible for both geno-
types. These genes may be potential candidates for 
development of transmission blocking or sequestration 
blocking vaccines or dual blocking vaccines.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1307 1-019-3678-2.
Additional file 1: Table S1 Summary of the de novo assembly of the 
Babesia bovis genome compared to the reference genome size for the 
chromosomes and organelles. The size of the reference genome is 
indicated and the relative size of each de novo assembled genome in 
percentage. Highlighted chromosomes were used for the analysis of 
recombination and genome similarity. 
Additional file 2: Table S2. Mapping statistics for reads to their respective 
de novo assembled genomes. Indicated are the number of paired-end 
reads generated after quality trimming, the number mapped to their 
respective de novo assembled genomes, the number of reads mapped 
in pairs; and the percentage reads mapped and the percentage reads 
mapped in pairs. 
Additional file 3: Table S3. Summary of the mapping coverages 
obtained for the major chromosomes de novo assembled for various B. 
bovis clones.
Page 14 of 15Mans et al. Parasites Vectors          (2019) 12:419 
Abbreviations
Bv80: Babesia bovis gene Bv80; S24: South African S24 vaccine strain obtained 
after 23 rapid needle passages of the S strain; 05-100: field strain obtained 
from bovine exhibiting clinical Babesia symptoms; 9512-S24: S24 vaccine 
strain grown in bovine 9512; 9547-05-100: field strain 05-100 grown in bovine 
9547; 9522-S17.2-cl: clone obtained by limiting dilution from the S17.2 vac-
cine strain; 9523-S17.2-cl: clone obtained by limiting dilution from the S17.2 
vaccine strain; 9526-S17.2-cl: clone obtained by limiting dilution from the 
S17.2 vaccine strain; 9480-S24×05-100: clone obtained by limiting dilution 
that derived from co-transmission of S24 and 05-100 grown in bovine 9480; 
9563-S24×05-100: clone obtained by limiting dilution that derived from 
co-transmission of S24 and 05-100 grown in bovine 9563; 9574-S24×05-100: 
clone obtained by limiting dilution that derived from co-transmission of S24 
and 05-100 grown in bovine 9574.
Acknowledgements
The Biotechnology Platform of the Agricultural Research Council is thanked for 
next-generation sequencing.
Authors’ contributions
BJM and MPC conceived and designed the experiments and performed data 
analysis. PCT performed tick transmission and animal experimental studies. 
BJM and RP performed molecular work (genomic DNA extraction, PCR and 
analysis). BJM performed bioinformatics. BJM and MPC wrote the manuscript. 
All authors read and approved the final manuscript.
Funding
The study was supported by Red Meat Research and Development South 
Africa (Project: OV14/06/C226) and the National Research Foundation (NRF) 
Incentive Funding for Rated Researchers (NRF-Mans).
Availability of data and materials
Sequence data supporting the findings of this study have been deposited in 
public sequence databases. Raw sequence reads have been deposited in the 
NCBI Short Read Archive (SRA, SRR9678899– SRR9678960) under Bioproject 
accession number PRJNA552727 and are available from http://www.ncbi.nlm.
nih.gov/Trace s/sra/.
Ethics approval and consent to participate
Ethical approval for this study was obtained from the Animal Ethics Commit-
tee of the ARC-OVI (ref. OV14/02/P001).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Epidemiology, Parasites and Vectors, ARC-Onderstepoort Veterinary Institute, 
Private Bag X05, Onderstepoort 0110, South Africa. 2 Department of Life 
and Consumer Sciences, University of South Africa, Florida, South Africa. 
Received: 5 June 2019   Accepted: 21 August 2019
References
 1. Bock R, Jackson L, De Vos A, Jorgensen W. Babesiosis of cattle. Parasitol-
ogy. 2004;129(Suppl. 1):247–69.
 2. Burrow HM, Mans BJ, Cardoso FF, Birkett MA, Kotze AC, Hayes BJ, et al. 
Towards a new phenotype for tick resistance in beef and dairy cattle: a 
review. Anim Prod Sci. 2019;59:1401–27.
 3. Burger TD, Barker SC, Shao R. Phylogenetic analysis of mitochon-
drial genome sequences indicates that the cattle tick, Rhipicephalus 
(Boophilus) microplus, contains a cryptic species. Mol Phylogenet Evol. 
2014;76:241–53.
 4. Low VL, Tay ST, Kho KL, Koh FX, Tan TK, Lim YA, et al. Molecular characteri-
sation of the tick Rhipicephalus microplus in Malaysia: new insights into 
the cryptic diversity and distinct genetic assemblages throughout the 
world. Parasit Vectors. 2015;8:341.
 5. Gothe R. Ticks in the South African zoological survey collection. XII. The 
genera Boophilus Curtice, 1891 and Margaropus Karsch, 1879. Onderste-
poort J Vet Res. 1967;34:81–107.
 6. Yeoman GH, Walker JB. The ixodid ticks of Tanzania: a study of the zooge-
ography of the Ixodidae of an East African country. London: Common-
wealth Institute of Entomology; 1967.
 7. Walker A, Bouattour A, Camicas J-L, Estrada-Peña A, Horak IG, Latif AA, 
et al. Ticks of domestic animals in Africa: a guide to identification of spe-
cies. Edinburgh: Bioscience Reports; 2003.
 8. Spickett AM. Ixodid ticks of major economic importance and their distri-
bution in South Africa. 1st ed. South Africa: Agri Connect; 2013.
 9. Nyangiwe N, Horak IG, Van der Mescht L, Matthee S. Range expansion of 
the economically important Asiatic blue tick, Rhipicephalus microplus, in 
South Africa. J S Afr Vet Assoc. 2017;88:e1–7.
 10. Horak IG, Heyne H, Williams R, Gallivan GJ, Spickett AM, Bezuidenhout DJ, 
et al. The ixodid ticks (Acari: Ixodidae) of southern Africa. Cham: Springer; 
2018.
 11. Baron S, van der Merwe NA, Maritz-Olivier C. The genetic relationship 
between R. microplus and R. decoloratus ticks in South Africa and their 
population structure. Mol Phylogenet Evol. 2018;129:60–9.
 12. Mans BJ, Featherston J, Kvas M, Pillay KA, de Klerk DG, Pienaar R, et al. 
Argasid and ixodid systematics: implications for soft tick evolution 
and systematics, with a new argasid species list. Ticks Tick Borne Dis. 
2019;10:219–40.
 13. Rodríguez-Mallon A. Developing anti-tick vaccines. Meth. Mol Biol. 
2016;1404:243–59.
 14. Rodriguez-Vivas RI, Jonsson NN, Bhushan C. Strategies for the control of 
Rhipicephalus microplus ticks in a world of conventional acaricide and 
macrocyclic lactone resistance. Parasitol Res. 2018;117:3–29.
 15. de Waal DT, Combrink MP. Live vaccines against bovine babesiosis. Vet 
Parasitol. 2006;138:88–96.
 16. Combrink MP, Carr G, Mans BJ, Marais F. Blocking Babesia bovis vaccine 
reactions of dairy cattle in milk. Onderstepoort J Vet Res. 2012;79:1–4.
 17. Florin-Christensen M, Schnittger L, Dominguez M, Mesplet M, Rodríguez 
A, Ferreri L, et al. Search for Babesia bovis vaccine candidates. Parassitolo-
gia. 2007;49(Suppl. 1):9–12.
 18. Callow LL, Mellors LT, McGregor W. Reduction in virulence of Babesia 
bovis due to rapid passage in splenectomized cattle. Int J Parasitol. 
1979;9:333–8.
 19. Gill AC, Cowman AF, Stewart NP, Kemp DJ, Timms P. Babesia bovis: 
Molecular and biological characteristics of cloned parasite lines. Exp 
Parasitol. 1987;63:180–8.
 20. Timms P, Stewart NP, De Vos AJ. Study of virulence and vector trans-
mission of Babesia bovis by use of cloned parasite lines. Infect Immun. 
1990;58:2171–6.
 21. Combrink MP, Troskie PC, de Klerk DG, Pienaar R, Latif AA, Mans BJ. Co-
transmission of the non-transmissible South African Babesia bovis S24 
vaccine strain during mixed infection with a field isolate. Ticks Tick Borne 
Dis. 2015;6:158–63.
 22. De Vos AJ. Immunogenicity and pathogenicity of three South African 
strains of Babesia bovis in Bos indicus cattle. Onderstepoort J Vet Res. 
1978;45:119–24.
 23. De Vos AJ, Bessenger R, Fourie CG. Virulence and heterologous strain 
immunity of South African and Australian Babesia bovis strains with 
reduced pathogenicity. Onderstepoort J Vet Res. 1982;49:133–6.
 24. Mason TE, Potgieter FT, van Rensburg L. The inability of a South African 
Babesia bovis vaccine strain to infect Boophilus microplus. Onderstepoort J 
Vet Res. 1986;53:143–5.
 25. Combrink MP, Troskie PC, Pienaar R, Latif AA, Mans BJ. Genotypic diversity 
in Babesia bovis field isolates and vaccine strains from South Africa. Vet 
Parasitol. 2014;199:144–52.
 26. Mans BJ, Pienaar R, Latif AA, Potgieter FT. Diversity in the 18S SSU rRNA 
V4 hyper-variable region of Theileria spp. in Cape buffalo (Syncerus caffer) 
and cattle from southern Africa. Parasitology. 2011;138:766–79.
 27. Figueroa JV, Chieves LP, Johnson GS, Buening GM. Detection of Babesia 
bigemina-infected carriers by polymerase chain reaction amplification. J 
Clin Microbiol. 1992;30:2576–82.
Page 15 of 15Mans et al. Parasites Vectors          (2019) 12:419 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 28. Dean DA, Wadl PA, Hadziabdic D, Wang X, Trigiano RN. Analyzing micros-
atellites using the QIAxcel System. Microsatellites. Totowa: Humana Press; 
2013. p. 223–43.
 29. Ambrosio RE, Potgieter FT, Nel N. A column purification procedure for the 
removal of leucocytes from parasite-infected bovine blood. Onderste-
poort J Vet Res. 1986;53:179–80.
 30. Pienaar R, Potgieter FT, Latif AA, Thekisoe OMM, Mans BJ. Mixed Theileria 
infections in free-ranging buffalo herds: implications for diagnosing 
Theileria parva infections in Cape buffalo (Syncerus caffer). Parasitology. 
2011;138:884–95.
 31. Brayton KA, Lau AO, Herndon DR, Hannick L, Kappmeyer LS, Berens SJ, 
et al. Genome sequence of Babesia bovis and comparative analysis of 
apicomplexan hemoprotozoa. PLoS Pathog. 2007;3:1401–13.
 32. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment 
search tool. J Mol Biol. 1990;215:403–10.
 33. Darling AC, Mau B, Blattner FR, Perna NT. Mauve: multiple alignment 
of conserved genomic sequence with rearrangements. Genome Res. 
2004;14:1394–403.
 34. Castresana J. Selection of conserved blocks from multiple alignments for 
their use in phylogenetic analysis. Mol Biol Evol. 2000;17:540–52.
 35. Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and 
effective stochastic algorithm for estimating maximum-likelihood phy-
logenies. Mol Biol Evol. 2015;32:268–74.
 36. Lau AOT, Kalyanaraman A, Echaide I, Palmer GH, Bock R, Pedroni MJ, 
et al. Attenuation of virulence in an apicomplexan hemoparasite results 
in reduced genome diversity at the population level. BMC Genomics. 
2011;12:410.
 37. Troskie PC, Latif AA, Mans BJ, Combrink MP. Efficacy of South Afri-
can Babesia bovis vaccine against field isolates. Ticks Tick Borne Dis. 
2017;8:671–4.
 38. Hutchings CL, Li A, Fernandez KM, Fletcher T, Jackson LA, Molloy JB, et al. 
New insights into the altered adhesive and mechanical properties of red 
blood cells parasitized by Babesia bovis. Mol Microbiol. 2007;65:1092–105.
 39. O’Connor RM, Long JA, Allred DR. Cytoadherence of Babesia bovis-
infected erythrocytes to bovine brain capillary endothelial cells provides 
an in vitro model for sequestration. Infect Immun. 1999;67:3921–8.
 40. Allred DR. Babesiosis: persistence in the face of adversity. Trends Parasitol. 
2003;19:51–5.
 41. Pedroni MJ, Sondgeroth KS, Gallego-Lopez GM, Echaide I, Lau AOT. Com-
parative transcriptome analysis of geographically distinct virulent and 
attenuated Babesia bovis strains reveals similar gene expression changes 
through attenuation. BMC Genomics. 2013;14:763.
 42. Rachinsky A, Guerrero FD, Scoles GA. Proteomic profiling of Rhipicephalus 
(Boophilus) microplus midgut responses to infection with Babesia bovis. 
Vet Parasitol. 2008;152:294–313.
 43. Kongsuwan K, Josh P, Zhu Y, Pearson R, Gough J, Colgrave ML. Exploring 
the midgut proteome of partially fed female cattle tick (Rhipicephalus 
(Boophilus) microplus). J Insect Physiol. 2010;56:212–26.
 44. Heekin AM, Guerrero FD, Bendele KG, Saldivar L, Scoles GA, Dowd SE, 
et al. Gut transcriptome of replete adult female cattle ticks, Rhipicephalus 
(Boophilus) microplus, feeding upon a Babesia bovis-infected bovine host. 
Parasitol Res. 2013;112:3075–90.
 45. Stewart NP. Differences in the life cycles between a vaccine strain and 
an unmodified strain of Babesia bovis (Babes, 1889) in the tick Boophilus 
microplus (Canestrini). J Protozool. 1978;25:497–501.
 46. Alzan HF, Lau AO, Knowles DP, Herndon DR, Ueti MW, Scoles GA, 
et al. Expression of 6-Cys gene superfamily defines Babesia bovis 
sexual stage development within Rhipicephalus microplus. PLoS One. 
2016;11:e0163791.
 47. Hussein HE, Bastos RG, Schneider DA, Johnson WC, Adham FK, Davis WC, 
et al. The Babesia bovis hap2 gene is not required for blood stage replica-
tion, but expressed upon in vitro sexual stage induction. PLoS Negl Trop 
Dis. 2017;11:e0005965.
 48. Jalovecka M, Sojka D, Ascencio M, Schnittger L. Babesia life cycle—when 
phylogeny meets biology. Trends Parasitol. 2019;35:356–68.
 49. Mehlhorn H, Schein E, Voigt WP. Light and electron microscopic study on 
developmental stages of Babesia canis within the gut of the tick Derma-
centor reticulatus. J Parasitol. 1980;66:220.
 50. Mehlhorn H, Schein E. The piroplasms: life cycle and sexual stages. Adv 
Parasitol. 1985;23:37–103.
 51. Mackenstedt U, Gauer M, Mehlhorn H, Schein E, Hauschild S. Sexual cycle 
of Babesia divergens confirmed by DNA measurements. Parasitol Res. 
1990;76:199–206.
 52. Weedall GD, Hall N. Sexual reproduction and genetic exchange in para-
sitic protists. Parasitology. 2015;142(Suppl. 1):120–7.
 53. Katzer F, Ngugi D, Oura C, Bishop RP, Taracha ELN, Walker AR, et al. Exten-
sive genotypic diversity in a recombining population of the apicompl-
exan parasite Theileria parva. Infect Immun. 2006;74:5456–64.
 54. Jiang H, Li N, Gopalan V, Zilversmit MM, Varma S, Nagarajan V, et al. High 
recombination rates and hotspots in a Plasmodium falciparum genetic 
cross. Genome Biol. 2011;12:R33.
 55. Henson S, Ebeling M, Pelle R, Certa U, Poveda L, Morzaria S, et al. High-
resolution genotyping and mapping of recombination and gene conver-
sion in the protozoan Theileria parva using whole genome sequencing. 
BMC Genomics. 2012;13:503.
 56. Wang S, Zickler D, Kleckner N, Zhang L. Meiotic crossover patterns: 
obligatory crossover, interference and homeostasis in a single process. 
Cell Cycle. 2015;14:305–14.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
